Zobrazeno 1 - 10
of 398
pro vyhledávání: '"Karin, Dieckmann"'
Autor:
Adrian Damek, Lars Kurch, Friedrich Christian Franke, Andishe Attarbaschi, Auke Beishuizen, Michaela Cepelova, Francesco Ceppi, Stephen Daw, Karin Dieckmann, Ana Fernández-Teijeiro, Tobias Feuchtinger, Jamie E. Flerlage, Alexander Fosså, Thomas W. Georgi, Dirk Hasenclever, Andrea Hraskova, Jonas Karlen, Tomasz Klekawka, Regine Kluge, Dieter Körholz, Judith Landman-Parker, Thierry Leblanc, Christine Mauz-Körholz, Markus Metzler, Jane Pears, Jonas Steglich, Anne Uyttebroeck, Dirk Vordermark, William Hamish Wallace, Walter Alexander Wohlgemuth, Dietrich Stoevesandt
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-9 (2024)
Abstract Hypodense volumes (HDV) in mediastinal masses can be visualized in a computed tomography scan in Hodgkin lymphoma. We analyzed staging CT scans of 1178 patients with mediastinal involvement from the EuroNet-PHL-C1 trial and explored correlat
Externí odkaz:
https://doaj.org/article/56fe25c1577a4d6ebc0c24ea6b216610
Autor:
Fiona Poyer, Karin Dieckmann, Michael Dworzak, Melanie Tamesberger, Oskar Haas, Neil Jones, Karin Nebral, Stefan Köhrer, Reinhard Moser, Gabriele Kropshofer, Christina Peters, Christian Urban, Georg Mann, Ulrike Pötschger, Andishe Attarbaschi, the Austrian Berlin‐Frankfurt‐Münster (BFM) Study Group
Publikováno v:
eJHaem, Vol 3, Iss 3, Pp 940-948 (2022)
Abstract Second malignant neoplasms (SMN) after primary childhood acute lymphoblastic leukemia (ALL) are rare. Among 1487 ALL patients diagnosed between 1981 and 2010 in Austria, the 10‐year cumulative incidence of an SMN was 1.1% ± 0.3%. There wa
Externí odkaz:
https://doaj.org/article/eb27500785414888a203fb3d6a9f37ae
Autor:
Ladislaia Wolff, Ariane Steindl, Petar Popov, Karin Dieckmann, Brigitte Gatterbauer, Georg Widhalm, Anna Sophie Berghoff, Matthias Preusser, Markus Raderer, Barbara Kiesewetter
Publikováno v:
Clinical & Experimental Metastasis. 40:217-226
Brain metastases (BM) in patients with thyroid cancer (TC) are rare with an incidence of 1% for papillary and follicular, 3% for medullary and up to 10% for anaplastic TC (PTC, FTC, MTC and ATC). Little is known about the characteristics and manageme
Autor:
Elisabeth Sophie Bergen, Amelie Binter, Angelika Martina Starzer, Gerwin Heller, Barbara Kiesel, Kristina Tendl-Schulz, Zsuzsanna Bago-Horvath, Julia Furtner, Johannes Leitner, Ruth Exner, Florian Fitzal, Karin Dieckmann, Georg Widhalm, Matthias Preusser, Anna Sophie Berghoff, Rupert Bartsch
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 13 (2021)
Background: Dual human epidermal growth factor receptor 2 (HER2) blockade with trastuzumab and pertuzumab (TP) is a standard therapy of metastatic and localized HER2-positive breast cancer (BC), but its activity in breast cancer brain metastases (BCB
Externí odkaz:
https://doaj.org/article/4eb2fe5fd3694a6a890ef4fe3c3a3a7b
Autor:
Lisa Mayr, Johannes Gojo, Andreas Peyrl, Amedeo A. Azizi, Natalia M. Stepien, Thomas Pletschko, Thomas Czech, Christian Dorfer, Sander Lambo, Karin Dieckmann, Christine Haberler, Marcel Kool, Irene Slavc
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
Embryonal tumor with multilayered rosettes (ETMR) is a rare, aggressive embryonal central nervous system tumor characterized by LIN28A expression and alterations in the C19MC locus. ETMRs predominantly occur in young children, have a dismal prognosis
Externí odkaz:
https://doaj.org/article/bc74f8f9dbc94b85bc346c956b44e4fc
Autor:
Maximilian J Mair, Sahra Pajenda, Barbara Kiesel, Georg Widhalm, Karin Dieckmann, Katharina Feldmann, Johannes Hainfellner, Ludwig Wagner
Publikováno v:
ESMO Open, Vol 5, Iss 6 (2020)
Background Immune-modulatory treatments have so far shown limited clinical activity in primary brain tumours. We aimed to investigate soluble programmed death receptor ligand 1 (sPD-L1) as systemic inflammation parameter in patients with brain tumour
Externí odkaz:
https://doaj.org/article/187c734408a344178ceb71d07c3ec6e8
Autor:
Sara R. Alcorn MD, MPH, PhD, Xian Chiong Zhou MS, Casey Bojechko PhD, Rodrigo A. Rubo BS, Michael J. Chen MD, Karin Dieckmann MD, Ralph P. Ermoian MD, Eric C. Ford PhD, Daria Kobyzeva MD, Shannon M. MacDonald MD, Todd R. McNutt PhD, Alexey Nechesnyuk MD, Kristina Nilsson MD, PhD, Hakan Sjostrand BS, Koren S. Smith MS, Markus Stock PhD, Erik J. Tryggestad PhD, Rosangela C. Villar MD, Brian A. Winey PhD, Stephanie A. Terezakis MD
Publikováno v:
Technology in Cancer Research & Treatment, Vol 19 (2020)
Background: Lower-dose cone-beam computed tomography protocols for image-guided radiotherapy may permit target localization while minimizing radiation exposure. We prospectively evaluated a lower-dose cone-beam protocol for central nervous system ima
Externí odkaz:
https://doaj.org/article/63272d7e5e25499289ab133f3b5a6ca6
Autor:
Stephen Daw, Dirk Hasenclever, Maurizio Mascarin, Ana Fernández-Teijeiro, Walentyna Balwierz, Auke Beishuizen, Roberta Burnelli, Michaela Cepelova, Alexander Claviez, Karin Dieckmann, Judith Landman-Parker, Regine Kluge, Dieter Körholz, Christine Mauz-Körholz, William Hamish Wallace, Thierry Leblanc, on behalf of the EuroNet Paediatric Hodgkin Lymphoma Group
Publikováno v:
HemaSphere, Vol 4, Iss 1, p e329 (2020)
Abstract. The objective of this guideline is to aid clinicians in making individual salvage treatment plans for pediatric and adolescent patients with first relapse or refractory (R/R) classical Hodgkin lymphoma (cHL). While salvage with standard dos
Externí odkaz:
https://doaj.org/article/d7343141f1694de29a9be7c881506871
Autor:
Maximilian J. Mair, Annette Leibetseder, Gerwin Heller, Rainer Puhr, Erwin Tomasich, Sebastian Goldberger, Teresa Hatziioannou, Adelheid Wöhrer, Georg Widhalm, Karin Dieckmann, Martin Aichholzer, Serge Weis, Tim von Oertzen, Julia Furtner, Josef Pichler, Matthias Preusser, Anna S. Berghoff
Publikováno v:
Clinical Cancer Research. 28:4565-4573
Purpose: The treatment of oligodendroglioma consists of tumor resection and radiochemotherapy. The timing of radiochemotherapy remains unclear, and predictive biomarkers are limited. Experimental Design: Adult patients diagnosed with isocitrate dehyd
Autor:
Friedrich Christian Franke, Adrian Damek, Jonas Steglich, Lars Kurch, Dirk Hasenclever, Thomas W Georgi, Walther Alexander Wohlgemuth, Christine Mauz‐Körholz, Dieter Körholz, Regine Kluge, Judith Landman‐Parker, William Hamish Wallace, Alexander Fosså, Dirk Vordermark, Jonas Karlen, Ana Fernández‐Teijeiro, Michaela Cepelova, Tomasz Klekawka, Andishe Attarbaschi, Francesco Ceppi, Andrea Hraskova, Anne Uyttebroeck, Auke Beishuizen, Karin Dieckmann, Thierry Leblanc, Martin Moellers, Boris Buerke, Dietrich Stoevesandt
Publikováno v:
Pediatric Blood and Cancer. Wiley-Liss Inc.
Background: Rebound thymic hyperplasia (RTH) is a common phenomenon caused by stress factors such as chemotherapy (CTX) or radiotherapy, with an incidence between 44% and 67.7% in pediatric lymphoma. Misinterpretation of RTH and thymic lymphoma relap